DOCTORS SIMILAR TO Dr. Srikanth M
Dr. Hüseyin Saffet Beköz- hematologist
Dr. Hüseyin Saffet Beköz
Hematologist
Diplomate
Post Graduation
Graduation
Istanbul, India
24 years of experience
Medipol University Hospital, İstanbul
Dr. Srikanth M
Hematologist
Consultant , Fellowship, Diploma, MBBS, 21 years of experienceChennai , India
About Doctor
- Dr. Srikanth M is a hematologist with experience of 21+ years.
- He has completed MBBS, Diploma and FRC. Plus, he has done Fellowship from Royal Marsden Hospital, UK.
- He is a member of American Society of Hematology, Royal College of Pathologist, British Society of Hematology, European Society of Hematology and Royal College of Physicians.
- Dr. Srikanth has written many research papers for national and international journals.
Specialization
Multiple Myeloma,
Leukemias,
Lymphomas
List Of Treatments
Wondering where to start?
(Get Free opinion, Quote, Medical Visa Invitation and Assistance at every step of your treatment.)
Work Experience of Dr. Srikanth M
Consultant, Apollo Hospitals, Greams Road, Chennai
Consultant, Royal Marsden Hospital
Consultant, St Geore Health Care London
Consultant, Hammersmith Hospital London
Consultant, Institute of Cancer Research, UK
Education
- Fellowship, Royal Marsden Hospital, UK
- Diploma
- MBBS
Paper Published
- Autophagy is a key myeloma survival pathway that can be manipulated therapeutically to enhance apoptosis. Blood 2010: 408
- Moore HE, Davenport EL, Smith EM, Muralikrishnan S, Dunlop AS, Walker BA, Krige D, Drummond AH, Hooftman L, Morgan GJ, Davies FE. Aminopeptidase Inhibition as a Targeted Treatment Strategy in Myeloma. Molecular Cancer Therapy,2009:762-770.
- Srikanth M, Davies F E, Morgan GJ. Update on novel drug combinations in Multiple Myeloma. Expert opinion on Investigational Drugs. 2008;17:1-12.
- Srikanth M, Jenner M, Wu P, Kaczmarek P, Dines S, Saso RM, Ethell M, M Potter M, Treleaven JG, Davies FE, Morgan GJ Survival and Outcome of Blastoid Variant Myeloma Following Treatment with DT-PACE. Haematologica. 2007;92:712.
- Davies FE, Srikanth M, Wu P, Jenner M, McCormack R, Cordero F, Trudel G, Morgan GJ. The Combination of Velcade, Idarubicin and Melphalan (VIM) Demonstrates Significant clinical activity in relapsed/refractory myeloma patients. Blood 2007;110:2727.
- Aronson L, Davenport EL, Giuntoli SG, Srikanth M, Smith E, Morgan GJ, Davies FE.
Location
Chennai
India
Vaidam is NABH certified healthcare discovery platform that will connect you to top-notch medical experts, hospitals, wellness options, and trusted travel partners in India to help identify and make the right healthcare choices.
You can search for the best hospitals in India to treat cancer and ailments of the heart, bones or kidney, read about them, view photographs of the facilities at the hospitals and the places at which the hospitals are located, and check the cost of treatment.
As soon as you post an enquiry, the patient relation team will collect details from you, share them with the doctors and hospitals on Vaidam's panel, and get a personalized treatment plan. We research to get quality treatment within your budget.
Vaidam concierge assists patients, to get medical Visa to travel to India, the best airline fares and arrangements for your stay. Our concierge also helps you with daily travel, language, and food concerns. Vaidam does everything to be your perfect host in India. All of Vaidam’s services are free of cost to patients.
If you are looking for medical care in New Delhi, Mumbai, Chennai, Hyderabad or Ahmedabad, Vaidam Health has a network in each of those cities.
